Injectio Natrii Chlorati Isotonica Polpharma

Sodium Chloride, the active ingredient in Injectio Natrii Chlorati Isotonica Polpharma, is an electrolyte solution presented as an injectable solution for epidural, intra‑articular and intramuscular use. It is employed to restore sodium and chloride balance and to support extracellular fluid volume in patients requiring fluid replacement.

GNH USA supplies Injectio Natrii Chlorati Isotonica Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU GMP standards and provides secure logistics for temperature‑controlled products to clinical facilities across Europe, Asia and the Americas.

Injectio Natrii Chlorati Isotonica Polpharma provides isotonic saline for clinical situations that require fluid and electrolyte management. - Fluid replacement: Restores intravascular volume and corrects dehydration in surgical or trauma patients. - Electrolyte balance: Supplies sodium and chloride to maintain normal plasma electrolyte concentrations. - Joint irrigation: Used to flush intra‑articular spaces during orthopedic procedures to remove debris and reduce infection risk. - Adjunct for epidural anesthesia: Dilutes local anesthetic agents and helps maintain epidural space pressure during regional blocks.

Sodium chloride injection may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Pain or burning at the injection site. - Mild hypernatremia when large volumes are given. - Local swelling or erythema.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Significant electrolyte imbalance leading to cardiac arrhythmia. - Pulmonary edema from fluid overload.

When using Injectio Natrii Chlorati Isotonica Polpharma, clinicians should observe several precautionary measures to ensure patient safety. - Assess baseline serum sodium and chloride levels before administration. - Use aseptic technique and inspect the solution for particulate matter. - Monitor patients for signs of fluid overload, especially those with cardiac or renal disease. - Adjust infusion rate in individuals with impaired renal function or heart failure. - Avoid use in patients with known hypersensitivity to sodium chloride solutions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride injection can interact with other therapies that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Co‑administration with hypertonic saline solutions, which may cause severe hypernatremia. - Concurrent high‑dose potassium supplements, increasing risk of electrolyte disturbances. - Use with certain diuretics (e.g., loop diuretics) without monitoring, leading to rapid shifts in sodium.

Moderate Interactions (Monitor Closely): - Concurrent use of ACE inhibitors or ARBs, which may potentiate renal sodium handling changes. - Combination with intravenous glucose solutions, requiring careful monitoring of serum osmolality. - Administration alongside other large‑volume IV fluids, necessitating assessment of total fluid balance.